Glycerol phenylbutyrate regulatory update

Horizon submitted an sNDA to FDA for Ravicti glycerol phenylbutyrate for chronic management of urea cycle disorders (UCDs) in patients 2 months of age to <2 years of age who cannot be managed by dieta...